Atlas Trials

A Rollover Protocol for Subjects Previously Treated With AGS-003

Clinical trial NCT01482949 · TERMINATED

Trial details

NCT number
NCT01482949
Sponsor
Argos Therapeutics
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2011-09-01
Primary completion
2018-05-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.